Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

about

TBX21 predicts prognosis of patients and drives cancer stem cell maintenance via the TBX21-IL-4 pathway in lung adenocarcinoma.

P2860

Q55318230-75EF853B-B54E-4E87-A375-A2A7E13F2EA0

P2860

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

Item

http://www.wikidata.org/entity/Q47215380

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

@en

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

@nl

type

Item

label

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

@en

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

@nl

prefLabel

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

@en

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

@nl

P1476

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

@en

P2093

Chunling Yuan

http://www.w3.org/2001/XMLSchema#string

Dan He

http://www.w3.org/2001/XMLSchema#string

Jianfeng Zhang

http://www.w3.org/2001/XMLSchema#string

Jinyan Zhang

http://www.w3.org/2001/XMLSchema#string

Rong Liang

http://www.w3.org/2001/XMLSchema#string

Xiaowen Zheng

http://www.w3.org/2001/XMLSchema#string

Yufeng Lv

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Global cancer statistics, 2012

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial

Cancer statistics, 2016

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

TCGA Expedition: A Data Acquisition and Management System for TCGA Data.

Four microRNAs Signature for Survival Prognosis in Colon Cancer using TCGA Data.

P304

29-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S155016

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yan Lin

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29317831

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5743192

http://www.w3.org/2001/XMLSchema#string

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

about

P2860

P2860

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932